Sandostatin is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Octreotide Acetate.
| Product ID | 0078-0182_5b689d42-d065-4d77-be63-0d30a07deb89 | 
| NDC | 0078-0182 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Sandostatin | 
| Generic Name | Octreotide Acetate | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS | 
| Marketing Start Date | 1988-10-21 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA019667 | 
| Labeler Name | Novartis Pharmaceuticals Corporation | 
| Substance Name | OCTREOTIDE ACETATE | 
| Active Ingredient Strength | 500 ug/mL | 
| Pharm Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 1988-10-21 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA019667 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2012-08-13 | 
| Marketing Category | NDA | 
| Application Number | NDA019667 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1988-10-21 | 
| Ingredient | Strength | 
|---|---|
| OCTREOTIDE ACETATE | 500 ug/mL | 
| SPL SET ID: | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0078-0180 | Sandostatin | octreotide acetate | 
| 0078-0181 | Sandostatin | octreotide acetate | 
| 0078-0182 | Sandostatin | octreotide acetate | 
| 0078-0183 | Sandostatin | octreotide acetate | 
| 0078-0184 | Sandostatin | octreotide acetate | 
| 0641-6174 | Octreotide Acetate | Octreotide Acetate | 
| 0641-6175 | Octreotide Acetate | Octreotide Acetate | 
| 0078-0647 | Sandostatin LAR Depot | octreotide acetate | 
| 0078-0648 | Sandostatin LAR Depot | octreotide acetate | 
| 0078-0811 | Sandostatin LAR Depot | octreotide acetate | 
| 0078-0818 | Sandostatin LAR Depot | octreotide acetate | 
| 0078-0825 | Sandostatin LAR Depot | octreotide acetate | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SANDOSTATIN  73572578  1412956 Live/Registered  | 
        SANDOZ PHARMACEUTICALS CORPORATION  1985-12-09  |